Physician profile
Jace Nye
NPI 1902450687
$1,962.44
in general payments reported to CMS, 2019-2025
20 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.80 · 2022: $106 · 2023: $811 · 2024: $658 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $405.49 | 2023-2025 | |
| Boston Scientific Corporation | $382.66 | 2021-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $234.41 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $212.75 | 2023-2025 | Uptravi, Opsumit |
| Cvrx, INC. | $102.58 | 2023-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $89.46 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $83.49 | 2022-2025 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $77.18 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $57.15 | 2022-2025 | Farxiga |
| Kiniksa Pharmaceuticals, LTD. | $56.79 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.73 | 2023-2025 | Jardiance |
| Scpharmaceuticals INC. | $45.26 | 2024-2025 | |
| Esperion Therapeutics, INC. | $31.07 | 2024 | Nexletol |
| Edwards Lifesciences Corporation | $26.30 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lexicon Pharmaceuticals, INC. | $20.84 | 2023 | Inpefa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.76 | 2023 | |
| Amgen INC. | $17.90 | 2023 | Repatha |
| Inspire Medical Systems, INC. | $16.46 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $14.78 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.38 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jace Nye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.